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Abstract. Pancreatic cancer (PC) is insidious with a high 
mortality rate due to the lack of symptomology prior to 
diagnosis. Mitochondrial involvement in PC development 
is becoming accepted, and exposure to cadmium (Cd) is 
suspected of being a risk factor for the development of PC; 
however, the mechanisms involved remain unclear. In this 
study, we examined the role of Cd as a mitochondrial toxicant 
and whether alterations in mitochondrial function may be an 
underlying cause for the development of PC. In this study, 
cadmium chloride (CdCl2)-mediated toxicity in hTERT-HPNE 
and AsPC-1 pancreatic cell lines was determined by MTT 
assay. We also investigated the release of LDH and the 
generation of free radicals. Mitochondrial toxicity assays were 
performed in media containing glucose (25 mM) or galactose 
(10 mM) and following exposure to CdCl2 (0-100 µM) followed 
by MTT assay. For the confirmation of mitochondrial toxicity, 
we measured the release of ATP following exposure to CdCl2. 
Initial experiments confirmed that exposure to CdCl2 did not 
reduce the viability of either cell line until a concentration of 
>10 µM was used. Non-linear analysis of the response curves 
revealed lethal concentration 50% (LC50) values for CdCl2 in 
the HPNE cells of 77 µM compared to 42 µM in the AsPC-1 
cells (P<0.01). The CdCl2-mediated mitochondrial toxic effects 
were greater in the HPNE cells, suggesting a heightened 
sensitivity to the effects of CdCl2, not due to elevated oxidative 
stress. Increased mitochondrial toxic sensitivity was indicated 
by a 73.4% reduction in IC50 values in the HPNE cells cultured 
in galactose compared to culture in glucose media, whereas 
the AsPC-1 cells exhibited a 58.8% reduction in IC50 values. In 
addition, the higher concentration of CdCl2 elicited a significant 
cell-dependent effect on ATP release in both cell lines, sugges-
tive of CdCl2 being a mitochondrial toxicant. Cell survival was 
unaffected following exposure to low concentrations of CdCl2; 
however, exposure did alter mitochondrial function (control 
cells > tumor cells). Therefore, the findings of this study indi-
cate that the mitochondria may be a site of action for cadmium 
in promoting tumor development.
Introduction
The effects of cadmium (Cd) on biological systems have been 
extensively studied; however, they remain relatively enigmatic. 
Cd has an exceptionally long half-life in biological systems 
(years) which may underlie the physiological changes associ-
ated with exposure to Cd. Cd is found widely throughout the 
environment and is one of the more abundant toxicants to 
which humans are exposed in both occupational and environ-
mental settings (1-3). Cadmium exerts toxic effects on many 
organs and systems of organs (4,5). Similarly, its endocrine 
disruptive activities have been described (6-9), as well as its 
hormetic effects (10). Cadmium, as well as Cd-containing 
compounds, have been classified as carcinogenic by the 
International Agency for Research on Cancer (11,12) based on 
epidemiological studies showing a causal connection with the 
development of lung cancer. Epidemiological studies have also 
implicated exposure to Cd to be involved in the development of 
other types of cancer, such as kidney cancer (13-15), prostate 
cancer (14,16,17), cancer of the testis (17), bladder cancer (18), 
breast cancer (19) and overall cancer mortality (20).
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The latest report on the global burden of cancer worldwide 
using GLOBOCAN 2018 estimated pancreatic cancer (PC) as 
the seventh leading cause of cancer-related mortality among 
both males and females with the projection that in the 28 coun-
tries of the European Union, this type of cancer will surpass 
breast cancer as the third leading cause of cancer-related 
mortality in the future (21). The prognosis of this type of cancer 
is very poor, mainly due to late-stage diagnosis. Hence, the 
elucidation of the etiology of this type of cancer and the iden-
tification of prognostic factors for it are of utmost importance. 
The quest for a legitimate biomarker to identify PC in the early 
stages is ongoing (22,23). A recent review article suggested the 
possible role of exposure to Cd in the development of PC (24). 
Some of the mechanisms involved in the carcinogenetic effects 
of Cd on the pancreas may be the induction of oxidative stress 
and interaction with bioelements, which have been observed 
and discussed in a number of studies (25-32). The development 
of PC is likely to be associated with the silencing of certain 
tumor suppressor genes and/or the activation of oncogenes, 
although the underlying molecular mechanisms remain unde-
fined (22,23,33,34). However, interactions between certain 
environmental chemicals, with Cd being one of them, and these 
genes can be expected. Furthermore, the micro-RNA-mediated 
regulation of pancreatic cell proliferation has been demon-
strated by Basu et al (35). Subsequently, microRNAs (miRNAs 
or miRs) were found to be present specifically in the mito-
chondria, originating from mitochondrial DNA and regulating 
genes coding for mitochondrial proteins in a direct manner, and 
consequently mitochondrial function (36). Concerning the role 
of Cd as a mitochondrial toxin, it has recently been studied, 
but with mixed results, suggesting that Cd may exert direct and 
indirect effects on the mitochondria (37-40). This ability of Cd 
to exert toxic effects on the mitochondria could certainly be 
one of the mechanisms of its carcinogenic effects on cells.
The nature of Cd-related mitochondrial toxicity has led to 
speculation that the toxicity observed can be mediated either 
by direct or indirect mechanisms. The aim of this study was 
to enhance our understanding of the effects of Cd on the mito-
chondria and to determine whether Cd is a direct or an indirect 
mitochondrial toxin. Current literature has been unclear and 
at times, conflicting (37). One concept that is becoming more 
accepted is that there is an organ-specificity regarding Cd 
toxicity. There is overlap between some of the major organs 
examined, although there are also differences in Cd-mediated 
responses. In the kidneys, there is speculation that Cd interferes 
with normal mitochondrial function, leading to increased oxida-
tive stress and apoptosis (40), which is further supported by 
in vitro studies utilizing human kidney cell lines showing that 
Cd directly alters mitochondrial membrane permeability and 
potential (39). Li et al extended these findings to isolated and 
purified mitochondria (38). In hepatic cells, exposure to Cd has 
been shown to decrease mitochondrial membrane permeability, 
but also to directly alter apoptotic pathways by increasing the 
activity of both caspase-3 and caspase-9, as well as increasing 
the activity of p53 (41). Recently, the effects of CdCl2 on the 
pancreas and pancreatic cells have been further described (24). 
In pancreatic β-cells (RIN-m5F cells), exposure to CdCl2 has 
been shown to result in the death of β-cells following increased 
oxidative stress followed by a downstream-mediated activation 
of apoptotic pathways regulated by the mitochondria (42). Some 
researchers have postulated that environmental or occupational 
exposure to Cd, and the resulting Cd-mediated death or damage 
to β-cells is an underlying cause of diabetes and obesity (43).
In this study, we examined the effects of cadmium 
chloride (CdCl2) on mitochondrial function due to the involve-
ment of mitochondria in the ‘Warburg effect’. The Warburg 
effect describes how tumor cells bypass oxidative phos-
phorylation [responsible for the generation of 38 adenosine 
triphosphates (ATPs)] and instead utilize aerobic glycolysis 
[generating only 2 ATPs, but other metabolites which could be 
useful in cellular proliferation (44)]. An advancement in our 
understanding of the peculiar phenomenon that was identi-
fied by Otto Warburg almost 100 years ago has progressed 
very little until the last 5‑10 years when a significant surge in 
interest has taken place (45,46). Although one single theory 
has not come to the forefront, numerous hypotheses have 
been presented, suggesting that the switch from oxidative 
phosphorylation to aerobic glycolysis signals the transition 
from a normal cell to a tumor cell (46). Another hypothesis 
is that switching to aerobic glycolysis can protect the tumor 
cell from sugar-induced death when glucose uptake is high, and 
by changing to a high production of lactate, pro-proliferative 
intermediates can be produced (47). Compounds, such as Cd, 
that damage the mitochondria promote a shift towards aerobic 
glycolysis, thus leading to tumor formation. Researchers that 
have examined toxicant [1-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine (MPTP)] damage to the mitochondria have reported 
that oxidative phosphorylation is decreased, that apoptotic 
pathways are altered and there is a bioenergetic shift in glucose 
utilization (48). Indirect genetic damage to the mitochondria 
that will result in epigenetic alterations has also been demon-
strated in tumor cells, as well as inherited genetic abnormalities 
that predispose or facilitate the progression of the Warburg 
effect in tumor cells (49). The apparent importance of the 
mitochondria and the Warburg effect has led researchers to 
postulate that either ‘turning’ oxidative phosphorylation ‘back 
on’ or shunting away from lactate production/utilization may 
be an effective means of controlling tumor growth (45,50).
Recently, we performed a literature search for ‘cadmium’, 
‘Warburg Effect’, or ‘Crabtree Effect’ and the references that 
we obtained were more specific for the effects of Cd on sugar 
utilization in yeast, which is what the Crabtree effect initially 
described (51,52). The effect of Cd on cellular energy utiliza-
tion is an area of research that needs to be addressed for a 
better understanding of the effects of Cd on the pancreas and 
on the development of PC, diabetes, obesity and other pancre-
atic dysfunctions. In this study, we designed a series of assays 
that would systematically address the Cd-mediated effects on 
pancreatic cells using a control epithelial cell line (HPNE) 
and the pancreatic tumor cell line, AsPC-1. The goals of 
these experiments were to first determine the level of toxicity 
following the exposure of both cell lines to Cd, and to then use 
subtoxic concentrations to determine mitochondrial toxicity. 
Our initial concentrations were determined using Cd concentra-
tions obtained from pancreatic tissue, from a pancreatic tumor, 
the area surrounding the tumor and from ‘healthy’ pancreatic 
tissue (53). After determining the threshold for Cd-mediated 
toxicity, we examined the production of free radicals following 
exposure to Cd and then used the glucose-galactose assay 
to assess the toxic potential of Cd on the mitochondria by 
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measuring the shift in the toxicity curve and change in IC50 
values comparing the glucose curve to the galactose curve. 
From these experiments, we aim to improve our understanding 
of Cd-mediated intracellular changes in pancreatic cells.
Materials and methods
Cell lines and cell culture maintenance. All cell culture experi-
ments were performed using standard Biosafety Level 2 (BSL-2) 
guidelines. The study was approved by the Oklahoma State 
University Center for Health Science Institutional Biosafety 
committee in compliance with all National Institutes of Health 
regulations. Cell lines purchased from the American Type 
Culture Collection (ATCC). Pancreatic hTERT-HPNE (‘human 
pancreatic Nestin‑expressing’ cells; ATCC® CRL-4023™, 
immortalized pancreatic control cells, referred to as ‘HPNE’) 
and AsPC-1 (ATCC® CRL-1682™, pancreatic tumor cells) cells 
were grown and maintained as described in the ATCC-suggested 
protocols. HPNE cell growth media consisted of DMEM base 
media with 2 mM glutamine, and 1.5 g/l sodium bicarbonate 
supplemented with M3 Base media supplement (M300F-500; 
Incell Corp.) at a ratio of 3:1. To produce complete growth media, 
5% fetal bovine serum, 10 ng/ml human epidermal growth factor, 
1 mg/ml glucose and 750 ng/ml Puromycin (Sigma-Aldrich and 
Corning) were added to the DMEM:M3 base. Base AsPC-1 
media was RPMI-1640 with 2 mM glutamine, and complete 
growth media consisted of supplementation with 10% fetal 
bovine serum, and 1% penicillin/streptomycin (Sigma-Aldrich 
and Corning). Assay media used in the cytotoxicity assays was 
a base MEM supplemented with 2 mM glutamine and 1% fetal 
bovine serum. Assay media was phenol-free and low serum to 
minimize the confounding factors associated with the influence 
of protective growth factors in serum. Cells were allowed to 
adhere for at least 24 h before exposure. Following adherence, 
growth media were removed and replaced with assay media 
containing the appropriate treatment(s).
Cell viability and cell growth assays. All lactate dehydroge-
nase (LDH) assays (Cytotox-ONE™ kit; G7891, Promega) 
were performed essentially as previously described (54). The 
HPNE and AsPC-1 cell lines (20-50,000 cells/well) were plated 
and allowed to adhere for at least 24 h prior to the assay. LDH 
assays determined i) the number of viable cells within the 
culture; ii) the percentage of the total number of cells that were 
viable. Initial serum-comparison assays experiments examined 
the effects of various serum concentrations on cell growth and 
viability. Following the removal of the growth media, MEM 
supplemented with 0% (control), or 1, 2.5, 5 and 10% fetal 
bovine serum was added to appropriate wells followed by incu-
bation at 37˚C in 5% CO2 for 48 h. Following exposure, the LDH 
assay was carried out according to the manufacturer's instruc-
tions. The ability to quantify dead and live cells is described in 
the following formula: {[(total RFU) - (Media RFU)] ÷ (total 
RFU)} x100. The amount of fluorescence produced was quanti-
fied using a Biotek plate reader (Biotek Instruments) set to an 
excitation wavelength of 485 nm and an emission wavelength 
of 530 nm.
Once we determined whether or not changing the serum 
concentration would affect cell viability and cell number, we 
exposed both the HPNE and AsPC-1 cells to 2 ppm (18 µM), 
6 ppm (54 µM) and 14 ppm (126 µM) CdCl2 for 48 h. We have 
previously analyzed human pancreatic tissue and measured 
the content of Cd (53). The highest concentration was found 
within the tumor, the intermediate concentration was in the 
region immediately surrounding the tumor zone, and the lowest 
concentration was found at a site distant from the tumor. We 
used the molecular contribution of Cd to CdCl2 and calculated 
the concentration of Cd alone. This assay was performed to 
aid in the identification of the threshold of toxicity associated 
with exposure to CdCl2. Following exposure for 48 h, both 
cell viability and the total number of cells were determined as 
described in the serum-comparison assays described above. 
The rationale for using CdCl2 as our form of Cd is based on 
existing literature and published studies using CdCl2 both in 
in vitro and in vivo studies (24,25,27,31,53). The use of CdCl2 
will strengthen conclusions comparing our findings to the 
existing literature using CdCl2.
Measurement of oxidative stress. Both cell lines were grown 
in 25 cm2 flasks and seeded into a 96‑well (black/clear bottom) 
plate at an initial density of 10-5 cells/ml (or 10-4 cells/well). 
The cells were allowed to adhere for 24 h and to initiate the 
assay, the growth media was removed followed by washing 
the cells (twice) with warmed PBS. The cells were then loaded 
with 100 µM DCFH‑diacetate (DCFH‑DA) for 30 min at 37˚C 
in 5% CO2, while being protected from light. Following the 
removal and washing with PBS, the cells were exposed to one 
of three treatments; control (PBS only; 0 µM CdCl2), 50 µM 
CdCl2 or 100 µM CdCl2. Baseline fluorescence was determined 
in the PBS-only group prior to the addition of CdCl2. The cells 
were returned to the incubator to allow for the continuation 
of the reaction. The plates were removed after 30, 60, 90 and 
120 min and the fluorescence resulting from the conversion 
of dichlorofluorescin (DCFH) to dichlorofluorescein (DCF) 
was measured using a Biotek plate reader set to an excitation 
wavelength of 485 nm and an emission wavelength of 530 nm. 
The amount of fluorescence detected is directly correlated to the 
amount of oxidative stress occurring within the cell. Data were 
then expressed as the means ± SEM of n=8 assayed in duplicate.
Determination of lethal concentration 50% (LC50) values for 
CdCl2. The HPNE and AsPC-1 cell lines were maintained as 
described above. The cells were plated at a final density of 
approximately 105 cells/ml in clear 96-well plates. The cells 
were allowed to adhere for at least 24 h and the media were 
carefully removed and assay media with the appropriate 
concentrations of CdCl2 (0-10-3 M) were added to the wells. 
Following 48 h of exposure, 12 mM stock (1.2 mM final concen-
tration) MTT (Molecular Probes) was added to each well and 
the plates were returned to the incubator (37˚C and 5% CO2) for 
4 h followed by the addition of detergent for another 3-4 h. The 
amount of insoluble formazan was determined by measuring 
the absorbance at 565 nm using the BioTek plate reader. Data 
were then expressed as the means ± SEM of n=6 in duplicate.
Mitochondrial toxicity assays. HPNE and AsPC-1 cell lines 
were plated at a final density of 20,000‑50,000 cells/well and 
allowed to adhere for at least 24 h prior to the assay. The initia-
tion of toxicant exposure begins by removing the growth media 
and replacing with DMEM supplemented with either 25 mM 
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glucose or 10 mM galactose. This method of determining 
mitochondrial toxicity is similar to that described in the study 
by Sanuki et al (55) and Dott et al (56). The treatment groups 
consisted of cells exposed to Cd (0.1-100 µM) or control (media 
only) for 4 h followed by the addition of 12 mM MTT dye 
(1.2 mM final concentration). The absorbance was measured at 
565 nm, and the data were then expressed as the means ± SEM 
of n=12 in duplicate.
To establish the association between cell death and the 
loss of ATP, we used a luciferin-based detection system 
(Mitochondrial ToxGlo™; Promega) (57). The principle of 
the mitochondrial toxicity tests is that substituting 10 mM 
galactose for 25 mM glucose will increase susceptibility to 
mitochondrial toxins (58-60). The cells were exposed to CdCl2 
(1 or 50 µM) for 48 h prior to the initiation of the assay. These 
two concentrations were selected based on 50 µM approxi-
mating 6 ppm, and 1 µM was significantly lower than our 
threshold of 10 µM. Following 30 min of incubation at 37˚C 
in a CO2 incubator, viability was determined by measuring the 
fluorescence (485 nmex/525 nmem) emitted. The second step in 
the multiplex was to quantify the amount of ATP present by 
directly adding the luciferin-based detection system into the 
wells that have already been quantified for cell viability with 
the amount of luminescence being directly proportional to the 
amount of ATP present. Collectively, by comparing the cellular 
responses in the two datasets, a better understanding of CdCl2 
can be obtained as a cellular toxicant that results in mito-
chondrial dysfunction or non-mitochondrial related cytotoxic 
mechanisms.
Effect of CdCl2 on mitochondrial permeability. To assess cell 
health, we utilized a dye that is permeable to the mitochondrial 
and will fluoresce red or green depending on the membrane 
potential of the mitochondria. A high mitochondrial membrane 
potential (ΔψM) is representative of a healthy cell, whereas a 
low ΔψM is indicative of an unhealthy cell. The higher the ratio, 
the greater the polarization of the mitochondrial membrane. We 
utilized the JC-1 kit (Cayman Chemical Co.) for this purpose. The 
cells were plated at approximately 105 cells/well and allowed to 
adhere for 24 h. Exposure was initiated by removing the growth 
media from each well and adding the treatment media with 
CdCl2 (1 µM), or the vehicle (water). The cells were returned to 
the incubator for 48 h at 37˚C and 5% CO2. Following exposure, 
the cells were prepared according to manufacturer instructions; 
staining was initiated by the addition of 10 µ JC-1 dye and the 
cells were returned to the incubator for 20 min. The fluores-
cence intensity was measured using the BioTek plate reader at 
535ex/595em to measure JC-1 aggregates (healthy cells; green) 
and then a second reading using 485ex/535em which measures 
JC-1 monomers (apoptotic/unhealthy cells; red).
Statistical analysis: All data were analyzed using GraphPad 
Prism software (version 7.04). Data from initial CdCl2 expo-
sure assays were analyzed by one-way ANOVA followed by 
Dunnett's post hoc comparison to control values. In the oxida-
tive stress and LDH assays, data were analyzed by two-way 
ANOVA (2x3 or cell line x concentration) using Sidak's or 
Tukey's test for multiple comparisons, respectively. All data 
are expressed as the means ± SEM of n=4 (ATP assay), n=6 
(MTT LC50 assay), n=8 (DCFH oxidative stress assay) or n=12 
(mitochondrial toxicity assay) performed in either duplicate or 
triplicate. In the LC50 and mitochondrial toxicity assays, the data 
were first fit by non‑linear single‑site nonlinear regression inhi-
bition curve (single-site) to determine the IC50 value for CdCl2 
in each media. A ≥3‑fold leftward shift in LC50 or IC50 values 
in the galactose group was indicative of mitochondrial toxicity. 
When curve‑fitting, we utilized the D'Agostino and Pearson 
Test for Normality (omnibus K2) to assure that the curves 
followed a Gaussian distribution. One-way analysis of variance 
was performed with Dunnett's test for post hoc comparison 
to control LC50 values. For individual comparisons of LC50 
values, a Student's t-test was used to compared cell lines and 
treatments. For analyzing the mitochondrial toxicity data using 
dual-labeling, we utilized a three-way ANOVA (2x2x2; cell 
type, concentration, media) design with Sidak's test for post hoc 
multiple comparisons. Data are presented first as the result of 
the ANOVA where appropriate (F-value) representing whether 
there was a significant association within the group, such as a 
concentration effect. Post-hoc multiple comparisons were then 
performed, usually comparing to the control value; however, the 
value obtained from the post-hoc comparison is labeled in the 
figures by a symbol. A significance level was set at P<0.05.
Results
Cell viability: Effect of exposure to Cd and low serum concen‑
tration: There is a need to perform assays in reduced serum. 
Fetal bovine serum contains multiple factors that have been 
known to scavenge free radicals and afford protection to the 
cells when exposed to a toxic insult (61-63). These assays were 
performed to assess changes in cell viability in the presence of 
reducing concentrations of serum (fetal bovine serum), as well 
as a change in basal media from the standard optimized growth 
media to MEM with minimal supplementation. In the HPNE 
cells (Fig. 1A), no marked differences (P=0.61) were observed 
in either viability between the serum groups or between the 
growth media and corresponding MEM. In the AsPC-1 cells, 
there was a robust increase (F5,41=27.34; P<0.0001) in viability 
in the presence of reduced serum (Fig. 1B). From 0 to 5% the 
AsPC-1 cells exhibited a 20-25% greater viability compared 
to the growth media. It was noteworthy that reduced serum 
improved the viability of AsPC-1 cells. Previous studies 
have suggested that reducing the serum concentration will 
reduce viability and cellular proliferation in a variety of cell 
lines (64,65). This study, at least to the best of our knowledge, 
is the first to examine the effects of a reduced serum concentra-
tion on AsPC-1 viability and growth.
Initial experiments examined the effects of CdCl2 on the 
viability of HPNE and AsPC-1 cells by exposing the cells to 
CdCl2 at final concentrations of 0, 2, 6 and 14 ppm (Table I). These 
concentrations were selected based on data from human studies 
showing 14 ppm CdCl2 in the core of a pancreatic tumor, with 
6 ppm on the tumor margin and 2 ppm associated with ‘healthy’ 
tissue distant from the tumor center (53). As evidenced by the 
data presented in Table I, we observed only minimal changes in 
viability or cell number in cells exposed to CdCl2. In the HPNE 
cells, we observed an effect of treatment, (approximately 5%) in 
both cell number and viability compared to the control values 
(F4,15=37.59; P<0.0001). Post hoc comparisons revealed no 
differences between the treatment and control groups. In the 
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AsPC-1 cells, exposure to CdCl2 (treatment effect) resulted in 
a significant change in both viability (F4,15=66.69; P<0.0001) 
and in cell number (F4,15=10.91; P=0.0002). Dunnett's post hoc 
analysis was used to compare changes in the treatment groups 
to the control values. Only exposure to the highest concentra-
tion of CdCl2, 14 ppm, elicited significant reductions in both 
cellular viability (51%) and cell number (54%). Collectively, 
these data suggest that the control HPNE cells are relatively 
resistant following changes in serum concentration, as well as 
CdCl2 exposure. We observed minimal changes in both cell 
viability, as well as in cell number which would be indicative 
of proliferation/growth changes. The AsPC-1 cells, on the other 
hand, were more sensitive to the changes in serum concen-
tration and exposure to CdCl2. Generally, only the highest 
concentration of CdCl2 elicited significant reductions in both 
cell viability and number. Subsequent experiments assessed 
CdCl2-mediated changes in oxidative stress and mitochondrial 
toxicity as a secondary means for CdCl2 exposure resulting in 
cellular damage.
To determine the LC50 value of CdCl2 in the HPNE and 
AsPC-1 cells, each cell line was incubated with 7 concentra-
tions of CdCl2 (1 to 1 mM) for 48 h, and cell viability was 
determined by MTT staining (n=6). Curves for both cell lines 
were best fit to a single‑site model (Fig. 2). Individual response 
curves were analyzed to assess the LC50 for CdCl2 in each assay 
run. LC50 data were compared for the HPNE (77.3±6.8 µM) 
and AsPC-1 (42.1±4.0 µM) cells by Student's t-test and we 
observed a significant (P=0.0013) 45.5% reduction in LC50 
values in the AsPC-1 group (Fig. 2, inset). We also compared 
our means at each concentration to their corresponding control 
values to determine the threshold at which we observed a 
significant decrease in cell viability. This threshold provides 
a value where CdCl2 effects are significantly different from 
the control and compliments our LC50 values. Using a one-way 
ANOVA with Dunnett's test to compare treatment groups 
to their corresponding control, we were able to identify the 
threshold at which the concentration yielded a significant 
reduction in cell number. The viability of both the HPNE 
(F6,35=92.27; P<0.0001) and AsPC-1 (F6,35=115; P<0.0001) cells 
was significantly affected by the increasing concentrations of 
CdCl2. The maximum concentration where we observed no 
reduction in viability was 10 µM in both cell lines. Therefore, 
although there was a slight rightward shift in LC50 values in 
the AsPC-1 group, the threshold for viability reduction was 
unaltered between the cell lines.
Cd‑mediated induction of oxidative stress. The precise role 
of CdCl2 in the generation of free radicals has been a topic of 
considerable discussion. It is clear that transition metals have 
been implicated in the generation of free radicals (66,67). There 
is also evidence to suggest that oxidative stress and associated 
Figure 1. Effects of reduced serum (fetal bovine serum) concentration on the viability of (A) HPNE cells; and (B) AsPC-1 cells. Reducing the fetal bovine 
serum concentration from 10 to 0% did not markedly alter HPNE viability compared to the growth media control. In the AsPC-1 cells, there was a generalized 
increase in cell viability from 20-25%, apart from the 10% FBS group. The data presented represent n=4 performed in duplicate and are expressed as the 
means ± SEM. Data were analyzed by one-way ANOVA followed by Sidak post hoc test for the comparisons of the treatment (fetal bovine serum) to the growth 
media cell viability. **P<0.01 compared to growth media control values.
Figure 2. Determination of LC50 values for CdCl2 in HPNE and AsPC-1 cells. 
Cells were plated in clear 96-well plate at approximately 10-5 cells/ml and 
allowed to adhere for 24 h. before the addition of assay media containing 
CdCl2 (1 to 1 mM). Cells were returned to the incubator for 48 h. MTT assay 
was performed as described in the Materials and methods and the data were 
best fit to a single‑site model using nonlinear iterative curve fitting (GraphPad 
Prism). Individual LC50 values were calculated for each curve (inset) and 
AsPC-1 cells exhibited a lower LC50 value compared to HPNE LC50 values 
(P<0.01). Data are expressed as the means ± SEM of 6 assays performed 
in duplicate (n=6). *P<0.01 compared to the HPNE LC50 value. LC50, lethal 
concentration 50%; CdCl2, cadmium chloride.
WALLACE et al:  CADMIUM-INDUCED CHANGES IN PANCREATIC MITOCHONDRIA150
inflammation are underlying causes of cancer (68,69). The 
role of CdCl2 is not as clear as with other metals such as 
iron, lead, mercury. In this study, the ability of 50 or 100 µM 
CdCl2 to increase oxidative stress in the HPNE and AsPC-1 
cells (Fig. 3A and B, respectively) was assessed by measuring 
DCF fluorescence. Prior to expsoure to CdCl2, basal DCF fluo-
rescence was measured to yield a baseline to which subsequent 
treatment values would be compared. The basal levels of DCF 
fluorescence were 57.7% higher in the AsPC‑1 cells compared to 
the HPNE values (555.8 and 352.4 RFU respectively; P<0.0001) 
at the initial 0-time-point. When comparing the means 
between the AsPC-1 and HPNE cells at 60 min of incubation, 
the trend was similar with the AsPC-1 cells, demonstrating 
a 48.4% increase in oxidative stress (595.2 vs. 401.2 RFU 
respectively; P<0.0001). Data were analyzed using a three-way 
ANOVA (cell type x time x treatment) and there was a clear 
association regarding cell type (F1,56=531.2; P<0.0001) and 
time (F4,105=162.6; P<0.0001) responses to CdCl2. In both cell 
lines, increasing the time of exposure resulted in an increased 
fluorescence. The trend for these increases was similar between 
the HPNE (F4,105=26.75; P<0.0001) and AsPC-1 (F4,105=59.71; 
P<0.0001) cells with no significant association between time 
and CdCl2 concentration in either the HPNE (F8,105=1.766; 
P=0.09) or AsPC-1 (F8,105=0.2748; P=0.92) cells.
Mitochondrial toxicity elicited by exposure to Cd. The next 
series of experiments examined the effects of increasing concen-
trations of CdCl2 on cellular toxicity in the HPNE (Fig. 4A) 
and AsPC-1 (Fig. 4B) cells. Following 4 h of exposure to 
CdCl2, cellular viability was measured by MTT assay. This 
assay examined the shift in IC50 value for CdCl2 following 
exposure to the metal in the presence of 25 mM glucose or 
10 mM galactose-containing media. A rightward shift in 
IC50 for the galactose curve of 2.5-3.0-fold would be indica-
tive of a mitochondrial toxin (55,56). All curves where fit to a 
single-site model with a r2 values of 0.72, 0.73, 0.75 and 0.86 
for HPNE-glucose, HPNE-galactose, AsPC-1-glucose and 
AsPC-1-galactose, respectively. After assessing the normality 
values, all curves passed as fitting normal Gaussian distribution 
(P-values of 0.07, 0.56, 0.17 and 0.92, respectively).
Figure 3. Oxidative stress in (A) HPNE and (B) AsPC-1 cells following exposure to CdCl2. Cells were grown and plated as described in the methods section. 
After loading with 100 µM DCFH, cells were washed twice with warm PBS and baseline fluorescence was measured (time 0). Treatment groups of (0 µM, 
PBS-only), and 50 or 100 µM CdCl2 were added to the appropriate treatment wells. DCF fluorescence was quantified at 30, 60, 90 and 120 min using a BioTek 
plate reader set at 485 nm(ex)/530 nm(em). The RFU values expressed were corrected for background (35‑48 RFU) for each group. There was a significant effect 
of treatment-concentration in both HPNE (F2,105=10.45; P<0.0001) and AsPC-1 (F2,105=16.45; P<0.0001) cells. Data are expressed as the means ± SEM of 
8 assays (n=8) performed in duplicate. CdCl2, cadmium chloride. *P<0.01 compared to the corresponding 0-time-point.
Table I. Effects of exposure to CdCl2 for 48 h on the live cell number and viability of HPNE and AsPC-1 cells.
 CdCl2 concentration --------------------------------------------------------------------------------------------------
 Growth media Low-serum MEM 2 ppm 6 ppm 14 ppm
HPNE
  Live cell no. (RFU) 3,711±100 3,591±71 3,478±70 3,585±52 3,518±87
  Viability (%) 84.2±0.3 81.9±0.2 80.7±0.4 80.6±0.2 78.6±0.5
AsPC-1
  Live cell no. (RFU) 15,501±1,518 15,247±1,206 12,318±231 12,048±1,033 7,054±678a
  Viability (%) 62.4±2.3 71.1±1.1 58.9±1.4 56.9±6.6 30.7±4.1a
aP<0.0001 compared to the growth media. Data are expressed as the means ± SEM, n=4. CdCl2, cadmium chloride.
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Individual IC50 values were obtained for each sample using 
non-linear curve fitting and graphically represented as the 
means ± SEM for each group (Fig. 5A). There was a signifi-
cant effect of media on the IC50 values (glucose vs. galactose; 
F1,44=25.38; P<0.0001) that was observed in both cell lines. 
Sidak post hoc analysis revealed that only the IC50 value in the 
HPNE‑galactose group was significantly (P<0.01) lower than 
that in the HPNE-glucose group (Fig. 5A). When examining 
the shift in IC50 values (Fig. 5B), we observed that there was 
almost a 2- to 4-fold rightward shift in IC50 values in both cell 
lines. The IC50 shift suggests that CdCl2 does act as a mitochon-
drial toxin in the HPNE and AsPC-1 cells.
Using a dual-labeling assay kit, we measured both cell 
viability (Fig. 6A) and ATP release from the mitochondria, 
which is indicative of mitochondrial toxicity (Fig. 6B). The use 
of the more sensitive dual-labeling system revealed a complex 
response pattern to the action of CdCl2 in both cell lines. The 
four possible outcomes from this assay are: i) No change in 
ATP signal + no change in membrane integrity = not a mito-
chondrial toxicant; ii) reduced ATP + increased membrane 
integrity = primary necrosis; iii) reduced ATP + no change in 
membrane integrity = mitochondrial toxin; and iv) very low ATP 
at all concentrations + discordant change in membrane integ-
rity = mitochondrial toxicant. Exposure to CdCl2 significantly 
(F1,24=214.5; P<0.0001) affected membrane integrity (Fig. 6A). 
The cytotoxicity response was also dependent on the type of 
media, glucose vs. galactose (F1,24=13.54; P=0.0012) and cell 
type, HPNE vs. AsPC-1 (F1,24=173.4; P<0.0001). There was a 
significant (F1,24=37.11; P<0.0001) association between the media 
and CdCl2 concentration. In each group, exposure to 50 µM 
CdCl2 resulted in a significant reduction (P<0.05) in viability 
compared to the corresponding 1 µM CdCl2 values in each of 
the groups. Viability in both the 1 and 50 µM CdCl2 groups 
in the galactose/AsPC‑1 group was significantly (P<0.05) lower 
than the corresponding 25 mM glucose viability values. Across 
the CdCl2 concentrations and glucose/galactose supplementa-
tion, the viability values were significantly (P<0.05) reduced 
in the AsPC-1 cells compared to the corresponding viability 
values in the HPNE cells.
When examining the levels of ATP, we observed a less 
robust change across he treatment groups (Fig. 6B), yet the 
trends were similar compared to the data observed from the 
Figure 4. Mitochondrial toxicity following exposure to various concentrations of CdCl2 in the presence of 25 mM glucose or 10 mM galactose. Cells were 
maintained in regular growth media until assayed. Cells were exposed to 0.01-100 µM CdCl2 for 4 h and the number of viable cells was estimated by MTT 
assay in the (A) HPNE and (B) AsPC-1 cells. Note the slight leftward shift in the curves for the 10 mM galactose group indicating a greater sensitivity to CdCl2 
toxicity. Data are expressed as the means ± SEM of 12 assays (n=12) performed in duplicate and represent a composite of all assays analyzed by nonlinear 
curve fitting ‑ single site inhibition analysis. CdCl2, cadmium chloride.
Figure 5. Comparison of CdCl2 IC50 values in HPNE and AsPC-1 cells following 4 h of exposure to CdCl2. Media contained either 25 mM glucose or 10 mM 
galactose. Individual IC50 values were obtained from the data in Fig. 4 by analyzing each curve independently and then grouped by cell type. IC50 values (A) are 
expressed as µM and the rightward fold-shift in mean IC50 values (B) are expressed as the means ± SEM of 12 assays (n=12) performed in duplicate. CdCl2, 
cadmium chloride. *P<0.01 compared to HPNE IC50 value with 25 mM glucose.
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cytotoxicity experiments. Exposure to CdCl2 significantly 
(F1,24=55.58; P<0.0001) affected membrane integrity (Fig. 6A). 
The cytotoxicity response was also dependent on the type 
of media, glucose vs. galactose (F1,24=22.67; P<0.0001) and 
cell type, HPNE vs. AsPC-1 (F1,24=9.10; P=0.006). There 
were two interactions that were significantly associated and 
these were media type x CdCl2 concentration (F1,24=21.03; 
P=0.0001) and cell type x CdCl2 concentration (F1,24=10.53; 
P=0.0034), suggesting that the CdCl2 concentration had a 
significant impact on both membrane integrity and ATP quan-
tity, depending on the media (glucose vs. galactose) type or 
cell type (HPNE vs. AsPC-1). The AsPC-1 cells exhibited a 
slightly higher sensitivity to the effects of CdCl2, as indicated 
in Fig. 6B. The sensitivity of the AsPC-1 cells was particularly 
visible at the higher concentration of 50 µM of CdCl2, with the 
reduction in ATP was more pronounced in the 10 mM galactose 
group. If there is a change in membrane integrity associated 
with the changes in ATP, then that would be indicative of a 
necrotic toxin, leading to a reduction in ATP. We observed two 
associated interactions, with both the media and the cell type 
being significantly associated with the concentration of CdCl2.
An additional measure of mitochondrial function is the 
measure of mitochondrial permeability (referred to as ΔψM). We 
used the JC-1 dye due to its ability to permeate the mitochon-
dria, and to either form aggregates (healthy cells) or monomers 
(unhealthy cells) which fluoresce at different wavelengths. We 
observed that CdCl2 (1 µM) had a significant effect on the 
health of the cells (F1,16=7.35; P=0.0184), slightly reducing the 
ratio of health/unhealthy cells in both cell lines (Fig. 7). Neither 
treatment group differed significantly from its corresponding 
control value.
Discussion
On the periodic table, some of the most toxic metals reside in 
the d-block or transition metal block. Cd is part of this group; 
however, Cd is somewhat different in that it is a fifth‑period 
element, unlike chromium, manganese, iron, and cobalt which 
are fourth-period elements. In addition, Cd is at the end of the 
transitional metal fifth‑period row which makes it a ‘post‑trans-
lational element’. Therefore, there are similarities between Cd 
and other metals that are known toxicants, carcinogens, and free 
radical generators, such as mercury, iron, chromium, cobalt, 
nickel and manganese, although additional studies are required 
to improve our understanding of the cellular and intracellular 
actions of Cd. In this study, we aimed to work towards that end. 
Initial experiments examined the effects of CdCl2 on viability 
and cell number in media containing decreasing concentrations 
of fetal bovine serum. We did this to confirm the lack of serum 
Figure 6. Determination of membrane integrity and ATP release following exposure to 1 or 50 µM CdCl2 in the HPNE and AsPC-1 cells. (A) Effects of expo-
sure to CdCl2 on membrane integrity following incubation in the presence of 25 mM glucose, or 10 mM galactose. AsPC-1 cells displayed a greater sensitivity 
to CdCl2 compared to the HPNE cell responses, and this great sensitivity was most evident when cells were incubated in the presence of 10 mM galactose. 
(B) Measurement of ATP release from damaged cells demonstrated a small ATP reduction in the AsPC-1 50 µM CdCl2 group. Incubation in the presence 
of 10 mM galactose revealed that AsPC-1 cells were most sensitive to the actions of CdCl2. Data represent the means ± SEM of 4 assays (n=4) performed in 
duplicate (aP<0.05 compared to the corresponding 25 mM glucose values; bP<0.05 compared to the corresponding HPNE group values; *P<0.05 compared to 
the corresponding 1 µM CdCl2 values). CdCl2, cadmium chloride.
Figure 7. Measurement of mitochondrial permeability using JC-1 dye fol-
lowing exposure to 1 µM CdCl2 in HPNE and AsPC-1 cells. Fluorescence 
intensity was measured at 535ex/595em to measure JC-1 aggregates (healthy 
cells; green) and then a second reading using 485ex/535em which measures 
JC-1 monomers (apoptotic/unhealthy cells; red). The ratio of green/red rep-
resents a relative number of cells which are ‘healthy’. There was a significant 
effect of treatment (F1,16=7.349; P=0.0154) with reductions in the ratio fol-
lowing exposure to 1 µM CdCl2 in both groups. Individual comparisons to 
control values did not reveal any difference in the fluorescent ratio in either 
cell line. Data represent the means ± SEM of 5 assays (n=5) performed in 
duplicate. CdCl2, cadmium chloride.
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effect for short exposure times. Other studies have reported that 
increasing the serum concentration up to 10% can affect the 
response of different cell types to toxicants (64,70). In this study, 
we reported that following exposure conducted in a low-serum 
environment, neither the growth or viability of neither cell line 
was significantly affected. The lack of effect aids in further 
in vitro studies and we can control the influence and impact 
that serum has on toxicity studies as a possible protectant. The 
lack of cytotoxicity observed following the exposure of HPNE 
cells to CdCl2 is not surprising since, control cells should have 
better defenses to protect against CdCl2-mediated damage. In 
addition, the 48-h exposure period may not be long enough 
for overt cytotoxic damage to be observed. Assay condition 
parameters are a consideration for further studies to avoid 
obscuring potential necrotic or apoptotic changes. Subsequent 
assays used a reduced serum to remove as many confounds as 
possible from additional toxicology testing. One variable we 
did not address in our studies is the possibility that low-level 
CdCl2 exposure may alter cellular responses, such as apoptosis.
The ability of elemental Cd to bioaccumulate in humans 
and concentrate in organs, such as the liver and kidneys can 
increase Cd-mediated toxicity over time (71). Exposure to CdCl2 
can result in apoptotic, as well as necrotic changes (72-74). 
The results of this study indicated that exposure to only the 
higher concentration of CdCl2 resulted in a reduction in cell 
viability and cell number. This reduction was only observed in 
the AsPC‑1 cells. This study intended to establish ‘threshold’ 
levels of exposure (concentration and duration) for use in 
subsequent mitochondrial toxicity experiments. Since we were 
attempting to find a threshold concentration for toxicity, it was 
not unexpected that we observed a lack of robust changes in 
cell viability, proliferation or cell number after a 48-h expo-
sure. Our understanding of Cd as an environmental toxicant 
is expanding, and its role in the development of cancer has 
become widely accepted (24,75-77). Health organizations 
have classified Cd as a carcinogen (76). However, the exact 
mechanism(s) through which Cd exerts these carcinogenic 
effects remain largely unknown. Questions have been put forth 
as to whether it is a ‘direct vs. indirect’ effect, or potentially an 
‘upstream vs. downstream’ effect. Further studies are required 
to describe the intracellular effects of Cd. In this study, we 
chose to target the mitochondria as an intracellular organelle 
that needs to function normally to aid the cell in providing the 
necessary energy requirements. When the mitochondria fail to 
function normally, tumor formation can follow (46).
The determination of a CdCl2 LC50 value in cell cultures is 
hard to find. It has previously been shown that the LC50 for CdCl2 
is approximately 70-80 µM in various aquatic organisms (77). 
Other researchers have indicated that the lethality of CdCl2 is 
dependent on both the concentration and the duration of the 
exposure (78). In hepatic and pituitary cultures, the reported 
LC50 values for CdCl2 range from 40-50 µM (78,79). In this 
study, our findings of 40‑70 µM fall within the LC50 range that 
has been reported elsewhere. The concentrations selected in the 
present study should represent concentrations that are: i) Below; 
ii) above; and iii) at the LC50 value. Caution was needed not 
to use concentrations that were too high which would prove 
lethal to a large percentage number of cells. That would skew 
our findings and conclusions since we would primarily be 
examining a subpopulation of cells that was resilient enough to 
guard against CdCl2 toxicity. Yet a concentration that was too 
low would not elicit a change in cellular function, and a change 
in apoptotic function in particular.
The secondary aim of this study was to establish and 
utilize ‘subtoxic’ concentrations of CdCl2 to assess oxidative 
stress elicited by exposure to CdCl2. Using approximately 
the mid-concentration, 6 ppm or 54 µM, of CdCl2, we can 
see that CdCl2 was only weakly a pro-oxidant, leading to a 
15-20% increase in free radicals over 120 min of exposure. 
Measuring DCF fluorescence relies on the direct generation 
of free radicals by CdCl2. In vivo studies have shown that the 
administration of CdCl2 does increase biomarker expression 
commonly associated with increased oxidative stress (80,81). 
Therefore, changes in the oxidative status of the cell alone 
cannot be sufficient alone to elicit intracellular changes leading 
to apoptotic changes (82). In the kidneys, researchers have postu-
lated that Cd interferes with normal mitochondrial function, 
leading to increased oxidative stress and apoptosis (38-40). In 
hepatic cells, CdCl2 exposure has been shown to decrease ΔψM, 
but also to directly alter apoptotic pathways by increasing the 
activity of both caspase-3 and caspase-9, as well as increasing 
the activity of p53 (41). In the pancreas, CdCl2 exposure has 
been shown to result in the death of β-cells following increased 
oxidative stress followed by a downstream-mediated activation 
of apoptotic pathways regulated by mitochondria (42). Other 
researchers have postulated that environment or occupational 
exposure to Cd, and the resulting Cd-mediated death or damage 
to β-cells is an underlying cause of diabetes and obesity (43). It 
is apparent that the Cd-mediated effects in the pancreas can 
alter β-cell function, hormonal responses, and may lead to the 
development of PC.
Healthy or ‘normal’ cells prefer oxidative phosphorylation 
(generation of 38 ATPs) to derive their energy (Crabtree), but 
immortalized cells lines may be adapted to using high glucose, 
generating ATP via glycolysis (only generates 2 ATPs), which 
will decrease the sensitivity of the cells to mitochondrial 
toxins (44). In this study, we examined the effects of CdCl2 on 
mitochondrial function and the Warburg effect, which involves 
the differential production of ATP in media containing glucose 
or galactose. Subsequently, by comparing the toxicity of a 
compound in the presence of glucose media, or the presence 
of galactose media, we can determine direct mitochondrial 
toxicity compared to other indirect mechanisms (55,57,58). The 
use of galactose-containing (10 mM) media will force the cell to 
increase their reliance on oxidative phosphorylation to generate 
ATP. The direct assessment of CdCl2 as a mitochondrial 
toxin suggested that CdCl2 is a weak mitochondrial toxicant. 
Comparisons of the glucose/galactose MTT curves in the pres-
ence of increasing concentrations of CdCl2 revealed an almost 
3-fold shift in IC50 values with glucose IC50 values > galactose 
IC50 values.
In support of this finding was our observation that ATP 
levels were reduced, primarily in AsPC-1 cells, with little 
concomitant changes in viability, suggestive of mitochondrial 
toxicity (57,59). These data suggest that the CdCl2 concentra-
tion has a significant impact on both membrane integrity and 
ATP quantity depending on media (glucose vs. galactose) type 
or cell type (HPNE vs. AsPC-1). When examining the data to 
determine whether CdCl2 is a mitochondrial toxin, or whether it 
elicits toxicity through another mechanism, the amount of ATP 
WALLACE et al:  CADMIUM-INDUCED CHANGES IN PANCREATIC MITOCHONDRIA154
present needs to be quantified. We would have expected a reduc-
tion in ATP in the presence of CdCl2 compared to control values 
suggesting a mitochondrial toxin. The cytotoxic response must 
then be examined, with no change in membrane integrity + reduc-
tion in ATP being indicative of being a mitochondrial toxin.
Following the addition of the JC-1 dye data, we observed 
only a small decrease in the ratio of healthy to unhealthy cells 
in both cell lines. A caveat of these findings is that we used 
1 µM CdCl2. The rationale for this concentration was that our 
threshold was approximately 10 µM CdCl2 when we began to 
see a reduction in cellular viability. We decided that a 10-fold 
lower concentration would be sufficient to induce changes in 
cellular function without resulting in a loss of viability, which 
would make our data difficult to interpret since the mito-
chondrial information would be from cells that were able to 
survive CdCl2 exposure. From our data, it can be hypothesized 
that CdCl2 is a weak mitochondrial toxin, with adverse effects 
evident at the highest CdCl2 concentrations of 10 µM or higher.
Although one single theory has not come to the forefront, 
numerous hypotheses have been presented suggesting that the 
switch from oxidative phosphorylation to aerobic glycolysis 
signals the transition from a normal cell to a tumor cell (46). 
Another hypothesis is that switching to aerobic glycolysis 
can protect the tumor cell from a sugar-induced death when 
glucose uptake is high, and by switching to a high production 
of lactate, pro-proliferative intermediates can be produced (47). 
Compounds, such as CdCl2, that damage the mitochondria 
promote a shift towards aerobic glycolysis, thus leading to 
tumor formation. Studies that have examined toxicant (MPTP) 
damage to the mitochondria have reported that oxidative phos-
phorylation is decreased, that apoptotic pathways are altered 
and there is a bioenergetic shift in glucose utilization (48). 
Indirect genetic damage to the mitochondria that will result in 
epigenetic alterations have has also been demonstrated in tumor 
cells, as well as inherited genetic abnormalities that predispose 
or facilitate the progression of the Warburg effect in tumor 
cells (49). The apparent importance of the mitochondria and 
the Warburg effect has led researchers to postulate that either 
‘turning’ oxidative phosphorylation ‘back on’ or shunting away 
from lactate production/utilization may be an effective means 
of controlling tumor growth (45,50). In this study, we demon-
strated a rightward shift in IC50 values for both the HPNE and 
AsPC-1 cells, suggesting that exposure to CdCl2 plays a role in 
mitochondrial dysfunction. Additional experiments supporting 
the finding of CdCl2 as a weak mitochondrial toxicant, include 
the investigation of the aspects of mitochondrial toxicity, such 
as changes in mitochondrial respiration, transition pore perme-
ability, and the activation of apoptotic peptides. The ability 
of Cd to accumulate within mammalian tissues is a variable 
that needs to be addressed due to the long biological half-life. 
This characteristic of Cd may result in toxicity when exposure 
concentrations are low, but exposure duration is extended. 
Additional studies are underway to examine the effects of 
CdCl2 exposure on intracellular function when subtoxic 
concentrations of CdCl2 are added to the growth media for 
extended periods of time (weeks). Exposure in this manner 
would better represent long-term chronic exposure that many 
individuals are subjected to in the environment.
Collectively, these data enhance our understanding of 
Cd-mediated intracellular toxicity. The results also lead us to 
additional questions. Unlike other well-studied metals, such as 
mercury, iron, nickel and manganese, CdCl2 appears to exert 
multiple weak effects, such as on oxidative stress, viability, ATP 
loss and oxidative phosphorylation as an energy source. CdCl2 
does behave as a weak mitochondrial toxicant as indicated by 
the 2- to 4-fold shift in IC50 values comparing the glucose and 
galactose curves. Since we observed only modest changes in 
viability, cell number and ATP release, it can be hypothesized 
that changes following low concentrations of CdCl2 are most 
likely due to a complex and cumulative set of small changes 
as opposed to substantial changes. The assessment of the 
direct vs. indirect effects of CdCl2 on cellular and mitochon-
drial function is essential. Potential CdCl2-mediated changes 
which occur upstream or downstream from the mitochondria 
will be pivotal in determining where and how CdCl2 is eliciting 
its cellular effects. Additional studies are underway to examine 
the molecular alterations in intracellular organelles associated 
with long-term CdCl2 exposure addressing our larger question 
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